Last reviewed · How we verify

NCT05141565: KEHS

The Kunshan Elderly Health Study

Active, enrolled Last updated 22 April 2024
What this trial tests

trial testing No intervention in Cardiovascular Diseases in 5,945 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
17 May 2021
Primary endpoint
31 December 2032
31 December 2032

Quick facts

Lead sponsorSoochow University
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment5,945
Start date17 May 2021
Primary completion31 December 2032
Estimated completion31 December 2032
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Soochow University

Who can join

65 and older, any sex, with Cardiovascular Diseases or Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Kunshan Elderly Health Study (KEHS) is a community-based prospective cohort study of chronic disease, mortality and associated factors among elderly adults in Kunshan, Eastern China.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

Other Soochow University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05141565.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing